16-81910645-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000564138.6(PLCG2):c.1859C>T(p.Thr620Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00141 in 1,613,962 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T620S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000564138.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLCG2 | NM_002661.5 | c.1859C>T | p.Thr620Met | missense_variant | 18/33 | ENST00000564138.6 | NP_002652.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLCG2 | ENST00000564138.6 | c.1859C>T | p.Thr620Met | missense_variant | 18/33 | 1 | NM_002661.5 | ENSP00000482457 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000821 AC: 125AN: 152258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00118 AC: 293AN: 249294Hom.: 2 AF XY: 0.00112 AC XY: 152AN XY: 135296
GnomAD4 exome AF: 0.00147 AC: 2155AN: 1461586Hom.: 4 Cov.: 32 AF XY: 0.00142 AC XY: 1035AN XY: 727124
GnomAD4 genome AF: 0.000820 AC: 125AN: 152376Hom.: 0 Cov.: 32 AF XY: 0.000752 AC XY: 56AN XY: 74514
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | PLCG2: BP4, BS1 - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
PLCG2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 26, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Familial cold autoinflammatory syndrome 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at